Onward Medical

Onward Medical company information, Employees & Contact Information

Explore related pages

Related company profiles:

ONWARD Medical is a medical technology company creating innovative therapies to restore movement, function, and independence in people with spinal cord injuries. ONWARD Medical’s work builds on more than a decade of basic science and preclinical research conducted at the world’s leading neuroscience laboratories. ARC Therapy, which can be delivered by implantable (ARC-IM) or external (ARC-EX) systems, is designed to deliver targeted, programmed spinal cord stimulation to restore movement and other functions in people with spinal cord injury, ultimately improving their quality of life. ONWARD Medical is headquartered in Eindhoven, the Netherlands. It maintains a Science and Engineering Center in Lausanne, Switzerland, and has a growing presence in the US. The Company has an academic partnership with .NeuroRestore, a collaboration between the Swiss Federal Institute of Technology (EPFL) and Lausanne University Hospital (CHUV).

Company Details

Employees
185
Founded
-
Address
Eindhoven, 5611 Zx, Nl
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Eindhoven
Looking for a particular Onward Medical employee's phone or email?

Onward Medical Questions

News

ONWARD Medical Publishes Closing of Bookbuild Offering - GlobeNewswire

ONWARD Medical Publishes Closing of Bookbuild Offering GlobeNewswire

ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating ARC-EX Adoption in the United States - Yahoo Finance

ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating ARC-EX Adoption in the United States Yahoo Finance

Portzamparc – BNP Paribas Group Initiates Coverage of - GlobeNewswire

Portzamparc – BNP Paribas Group Initiates Coverage of GlobeNewswire

ONWARD Medical Schedules Webcast to Provide Q1 2025 Business Update and Year-To-Date Highlights - Yahoo Finance

ONWARD Medical Schedules Webcast to Provide Q1 2025 Business Update and Year-To-Date Highlights Yahoo Finance

ONWARD Medical NV - Via Ritzau

ONWARD Medical NV Via Ritzau

Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blood Pressure Regulation after Spinal Cord Injury Using ONWARD ARC-IM Therapy - Yahoo Finance

Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blood Pressure Regulation after Spinal Cord Injury Using ONWARD ARC-IM Therapy Yahoo Finance

ONWARD Medical Files 510(k) with US FDA for ARC-EX System Home Use and Submits CE Mark Application - Yahoo Finance

ONWARD Medical Files 510(k) with US FDA for ARC-EX System Home Use and Submits CE Mark Application Yahoo Finance

ONWARD Medical Announces the Appointment of Lucas Buchanan to its Board of Directors - GlobeNewswire

ONWARD Medical Announces the Appointment of Lucas Buchanan to its Board of Directors GlobeNewswire

ONWARD Medical Establishes US ADR Program and Begins Trading on OTCQX Best Market - GlobeNewswire

ONWARD Medical Establishes US ADR Program and Begins Trading on OTCQX Best Market GlobeNewswire

ONWARD Medical Receives CE Mark for ARC-EX, Enabling Commercial Launch of Breakthrough Spinal Cord Stimulation System in Europe - Yahoo! Finance UK

ONWARD Medical Receives CE Mark for ARC-EX, Enabling Commercial Launch of Breakthrough Spinal Cord Stimulation System in Europe Yahoo! Finance UK

ONWARD Medical Announces First Commercial Sales of ARC-EX System - GlobeNewswire

ONWARD Medical Announces First Commercial Sales of ARC-EX System GlobeNewswire

ONWARD Medical's ARC-EX System Now Available on US Veterans Affairs Online Procurement Platforms - GlobeNewswire

ONWARD Medical's ARC-EX System Now Available on US Veterans Affairs Online Procurement Platforms GlobeNewswire

ONWARD Medical Adds Entrepreneur and Neurotechnology Thought Leader Tim Denison, PhD to its Board of Directors - Yahoo Finance

ONWARD Medical Adds Entrepreneur and Neurotechnology Thought Leader Tim Denison, PhD to its Board of Directors Yahoo Finance

ONWARD Medical Receives FDA De Novo Classification and US - GlobeNewswire

ONWARD Medical Receives FDA De Novo Classification and US GlobeNewswire

ONWARD Medical Demonstrates Commercial Traction and Advances Pipeline in the First Half of 2025 - GlobeNewswire

ONWARD Medical Demonstrates Commercial Traction and Advances Pipeline in the First Half of 2025 GlobeNewswire

ONWARD Medical Reports Full Year 2024 Financial and Operating Results and Shares 2025 Year-to-Date Highlights - Yahoo Finance

ONWARD Medical Reports Full Year 2024 Financial and Operating Results and Shares 2025 Year-to-Date Highlights Yahoo Finance

ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System - GlobeNewswire

ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System GlobeNewswire

ONWARD Medical Successfully Raises Over EUR 50 Million in Capital Increase - GlobeNewswire

ONWARD Medical Successfully Raises Over EUR 50 Million in Capital Increase GlobeNewswire

ONWARD Medical Builds Commercial Momentum for the ARC-EX - GlobeNewswire

ONWARD Medical Builds Commercial Momentum for the ARC-EX GlobeNewswire

Reeve Foundation Partner, ONWARD Medical, Announces World’s First FDA-Approved Non-Invasive Spinal Cord Stimulation System for People with Chronic Spinal Cord Injury - Christopher & Dana Reeve Foundation

Reeve Foundation Partner, ONWARD Medical, Announces World’s First FDA-Approved Non-Invasive Spinal Cord Stimulation System for People with Chronic Spinal Cord Injury Christopher & Dana Reeve Foundation

ONWARD Medical Advances Brain-Computer Interface Leadership with Fourth and Fifth Successful BCI Implants - GlobeNewswire

ONWARD Medical Advances Brain-Computer Interface Leadership with Fourth and Fifth Successful BCI Implants GlobeNewswire

ONWARD Medical Announces First-in-Human Use of ARC-IM - GlobeNewswire

ONWARD Medical Announces First-in-Human Use of ARC-IM GlobeNewswire

€10.20 Target Price — ONWARD Medical Gains Portzamparc Buy Coverage; ARC-EX Cleared in U.S. & Europe - Stock Titan

€10.20 Target Price — ONWARD Medical Gains Portzamparc Buy Coverage; ARC-EX Cleared in U.S. & Europe Stock Titan

ONWARD® Medical and Partners Awarded Christopher & Dana Reeve Foundation Grant to Further Study Brain-Computer Interface System - Yahoo Finance

ONWARD® Medical and Partners Awarded Christopher & Dana Reeve Foundation Grant to Further Study Brain-Computer Interface System Yahoo Finance

ONWARD® Medical Reaffirms 2024 Strategic Priorities and Releases Unaudited Q2 Financial Highlights - Yahoo Finance

ONWARD® Medical Reaffirms 2024 Strategic Priorities and Releases Unaudited Q2 Financial Highlights Yahoo Finance

ONWARD Medical Announces Publication of One-Year Study Showing Benefit of Sustained Access to ARC-EX Therapy - GlobeNewswire

ONWARD Medical Announces Publication of One-Year Study Showing Benefit of Sustained Access to ARC-EX Therapy GlobeNewswire

40 ARC-EX Systems Sold — ONWARD Medical Secures CE Mark, FDA IDE for ARC-IM to Start Pivotal Study - Stock Titan

40 ARC-EX Systems Sold — ONWARD Medical Secures CE Mark, FDA IDE for ARC-IM to Start Pivotal Study Stock Titan

ONWARD® Medical Signs Agreement with CEA for Exclusive Rights to Clinatec’s WIMAGINE® Brain-Computer Interface (BCI) Technology - Yahoo Finance

ONWARD® Medical Signs Agreement with CEA for Exclusive Rights to Clinatec’s WIMAGINE® Brain-Computer Interface (BCI) Technology Yahoo Finance

ONWARD Medical gets exclusive rights to Clinatec’s WIMAGINE BCI technology - Today's Medical Developments

ONWARD Medical gets exclusive rights to Clinatec’s WIMAGINE BCI technology Today's Medical Developments

Revolutionary Spinal Cord Blood Pressure Device from ONWARD Gets FDA Green Light for Major Trial - Stock Titan

Revolutionary Spinal Cord Blood Pressure Device from ONWARD Gets FDA Green Light for Major Trial Stock Titan

ONWARD® Medical Successfully Raises EUR 50 Million in an - GlobeNewswire

ONWARD® Medical Successfully Raises EUR 50 Million in an GlobeNewswire

ONWARD® Medical Successfully Raises €20 Million in a - GlobeNewswire

ONWARD® Medical Successfully Raises €20 Million in a GlobeNewswire

ONWARD® Medical Obtains Debt Financing with up to €52.5 Million Secured Loan from Runway Growth Capital LLC - GlobeNewswire

ONWARD® Medical Obtains Debt Financing with up to €52.5 Million Secured Loan from Runway Growth Capital LLC GlobeNewswire

ONWARD® Reports 2023 Half Year Results and Business Update - Yahoo Finance

ONWARD® Reports 2023 Half Year Results and Business Update Yahoo Finance

Stifel Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 12.00 - Yahoo! Finance UK

Stifel Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 12.00 Yahoo! Finance UK

ONWARD Awarded European Innovation Council Grant to Develop Brain-Spine Interface Technology - Business Wire

ONWARD Awarded European Innovation Council Grant to Develop Brain-Spine Interface Technology Business Wire

ONWARD Announces First Patient Enrollment in HemON Study and First-in-Human Use of its ARC - Business Wire

ONWARD Announces First Patient Enrollment in HemON Study and First-in-Human Use of its ARC Business Wire

ONWARD Announces Completion of Enrollment in the Up-LIFT Pivotal Trial of ARC Therapy for Spinal Cord Injury - Via TT

ONWARD Announces Completion of Enrollment in the Up-LIFT Pivotal Trial of ARC Therapy for Spinal Cord Injury Via TT

Top Onward Medical Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant